WADEBRIDGE & CAMEL ESTUARY PRACTICE
BROOKLYN, WADEBRIDGE
HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 15 | 16 | 93.8% | |
| HF 4 | 2011 | 17 | 18 | 94.4% | |
| HF 4 | 2012 | 16 | 17 | 94.1% | |
| HF 4 | 2013 | 21 | 25 | 84.0% | |
| HF004 | 2014 | 12 | 12 | 100.0% | |
| HF004 | 2015 | 16 | 18 | 88.9% | |
| HF004 | 2016 | 16 | 18 | 88.9% | |
| HF004 | 2017 | 18 | 23 | 78.3% | |
| HF004 | 2018 | 20 | 23 | 87.0% | |
| HF004 | 2019 | 28 | 31 | 90.3% | |
| HF004 | 2020 | 27 | 31 | 87.1% | |
| HF006 | 2021 | 45 | 53 | 84.9% | |
| HF006 | 2022 | 81 | 93 | 87.1% | |
| HF006 | 2023 | 103 | 126 | 81.7% |
